Augmentin is the safest choice for pregnancy
Among the three options, Augmentin (amoxicillin-clavulanate) is the safest antibiotic for use during pregnancy, followed by Zithromax (azithromycin) as an acceptable alternative, while Levaquin (levofloxacin) should be avoided unless absolutely necessary.
Safety Profile by Medication
Augmentin (Amoxicillin-Clavulanate): First Choice
Augmentin is classified as FDA Pregnancy Category B and rated as "Compatible" for pregnancy use 1. The evidence strongly supports its safety:
- No teratogenic risk: Multiple large studies confirm no increased risk of major congenital malformations with first-trimester exposure 2, 3
- Established safety data: A population-based study of 101,615 pregnancies found no association between first-trimester amoxicillin-clavulanate exposure and major malformations (adjusted RR 1.09,95% CI 0.98-1.20) 2
- Very low specific risks: While there is theoretical concern about oral clefts during organogenesis, the risk is very low 1
Important caveat: Amoxicillin-clavulanate is not recommended in women at risk of preterm delivery due to a very low risk of necrotizing enterocolitis in the fetus 1. However, recent evidence from 2022 challenges this concern, suggesting this risk may have been overstated based on methodological limitations of earlier studies 4.
Zithromax (Azithromycin): Acceptable Alternative
Azithromycin is classified as FDA Pregnancy Category B and rated as "Probably safe" 1. It represents a reasonable second-line option:
- No clear teratogenic signal: Studies of 123 pregnancies found no statistically significant differences in major malformations (3.4% exposed vs 2.3% disease-matched controls) 5
- Conflicting data on outcomes: Some studies suggest possible increased risks of miscarriage, cardiovascular malformations, and preterm birth, while others show no such associations 6
- Minimal fetal risk: Recent CDC guidelines (2025) include azithromycin as an alternative option for prophylaxis, noting it "poses minimal risk to the fetus" 7
- Very low breastfeeding concern: Risk of hypertrophic pyloric stenosis in infants exposed during first 13 days of breastfeeding only (not after 2 weeks) 1
Levaquin (Levofloxacin): Avoid Unless Necessary
Levofloxacin is classified as FDA Pregnancy Category C and should generally be avoided 8:
- Animal studies show concerns: While not teratogenic in rats at high doses, there are theoretical risks 8
- Limited human safety data: The FDA label states "no adequate and well-controlled studies in pregnant women" and recommends use "only if the potential benefit justifies the potential risk to the fetus" 8
- Historical concerns about cartilage damage: Animal studies with fluoroquinolones suggested fetal cartilage damage, though recent systematic reviews found no evidence of adverse maternal or fetal outcomes in humans 7
- Reserved for specific situations: Recent CDC guidelines (2025) list fluoroquinolones as first-line only for serious infections like tularemia where benefits clearly outweigh risks 7
Clinical Decision Algorithm
Use this approach when selecting antibiotics in pregnancy:
- First choice: Prescribe Augmentin for most bacterial infections requiring these three options
- If preterm delivery risk exists: Switch to azithromycin instead of Augmentin
- If penicillin allergy: Use azithromycin as the primary alternative
- Reserve levofloxacin for: Life-threatening infections where other options have failed or are contraindicated, and only after discussing risks/benefits with the patient
Key Takeaway
The hierarchy of safety is clear: Augmentin > Zithromax > Levaquin. Augmentin has the most robust safety data with compatible pregnancy classification, azithromycin is probably safe with some conflicting data, and levofloxacin should be reserved for situations where safer alternatives are inadequate.